ERNA vs VTR · P/E 0.0, rev $582.0K vs P/E 149, rev $4.92B
Eterna Therapeutics Inc (ERNA) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the ERNA and VTR stock pages for the full models.
Not investment advice.